These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35497510)

  • 61. Targeting multiple conformations of SARS-CoV2 Papain-Like Protease for drug repositioning: An in-silico study.
    Ismail MI; Ragab HM; Bekhit AA; Ibrahim TM
    Comput Biol Med; 2021 Apr; 131():104295. PubMed ID: 33662683
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Exploring Cannabinoids as Potential Inhibitors of SARS-CoV-2 Papain-like Protease: Insights from Computational Analysis and Molecular Dynamics Simulations.
    Holmes J; Islam SM; Milligan KA
    Viruses; 2024 May; 16(6):. PubMed ID: 38932170
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 3-chymotrypsin-like protease in SARS-CoV-2.
    Al Adem K; Ferreira JC; Villanueva AJ; Fadl S; El-Sadaany F; Masmoudi I; Gidiya Y; Gurudza T; Cardoso THS; Saksena NK; Rabeh WM
    Biosci Rep; 2024 Aug; 44(8):. PubMed ID: 39036877
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease.
    Chiou WC; Chen JC; Chen YT; Yang JM; Hwang LH; Lyu YS; Yang HY; Huang C
    Biochem Biophys Res Commun; 2022 Feb; 591():130-136. PubMed ID: 33454058
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Large-Scale Virtual Screening for the Discovery of SARS-CoV-2 Papain-like Protease (PLpro) Non-covalent Inhibitors.
    Garland O; Ton AT; Moradi S; Smith JR; Kovacic S; Ng K; Pandey M; Ban F; Lee J; Vuckovic M; Worrall LJ; Young RN; Pantophlet R; Strynadka NCJ; Cherkasov A
    J Chem Inf Model; 2023 Apr; 63(7):2158-2169. PubMed ID: 36930801
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2.
    Bhattacharya K; Bordoloi R; Chanu NR; Kalita R; Sahariah BJ; Bhattacharjee A
    J Genet Eng Biotechnol; 2022 Mar; 20(1):43. PubMed ID: 35262828
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hydrogen bonding penalty used for virtual screening to discover potent inhibitors for Papain-Like cysteine proteases of SARS-CoV-2.
    Zhao G; Liu X; Wang S; Bai Z; Zhang S; Wang Y; Yu H; Xu X
    Chem Biol Drug Des; 2022 Oct; 100(4):502-514. PubMed ID: 35792890
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic.
    Muteeb G; Alshoaibi A; Aatif M; Rehman MT; Qayyum MZ
    Appl Biol Chem; 2020; 63(1):79. PubMed ID: 33251389
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery.
    Fu Z; Huang B; Tang J; Liu S; Liu M; Ye Y; Liu Z; Xiong Y; Zhu W; Cao D; Li J; Niu X; Zhou H; Zhao YJ; Zhang G; Huang H
    Nat Commun; 2021 Jan; 12(1):488. PubMed ID: 33473130
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Screening and identification of potential MERS-CoV papain-like protease (PLpro) inhibitors; Steady-state kinetic and Molecular dynamic studies.
    Ali Dahhas M; M Alkahtani H; Malik A; Almehizia AA; Bakheit AH; Akber Ansar S; AlAbdulkarim AS; S Alrasheed L; Alsenaidy MA
    Saudi Pharm J; 2023 Feb; 31(2):228-244. PubMed ID: 36540698
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS-COV-2 targeting main protease and papain-like protease.
    Choudhary S; Nehul S; Singh A; Panda PK; Kumar P; Sharma GK; Tomar S
    IUBMB Life; 2024 May; 76(5):228-241. PubMed ID: 38059400
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Stigmastane-type steroid saponins from the leaves of
    Van PP; Ngo Van H; Quang MB; Duong Thanh N; Nguyen Van D; Thanh TD; Tran Minh N; Thi Thu HN; Quang TN; Thao Do T; Thanh LP; Do Thi Thu H; Le Tuan AH
    Nat Prod Res; 2024; 38(4):601-606. PubMed ID: 36924396
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Is oseltamivir suitable for fighting against COVID-19: In silico assessment, in vitro and retrospective study.
    Tan Q; Duan L; Ma Y; Wu F; Huang Q; Mao K; Xiao W; Xia H; Zhang S; Zhou E; Ma P; Song S; Li Y; Zhao Z; Sun Y; Li Z; Geng W; Yin Z; Jin Y
    Bioorg Chem; 2020 Nov; 104():104257. PubMed ID: 32927129
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Binding of SARS-CoV Covalent Non-Covalent Inhibitors to the SARS-CoV-2 Papain-Like Protease and Ovarian Tumor Domain Deubiquitinases.
    Sivakumar D; Stein M
    Biomolecules; 2021 May; 11(6):. PubMed ID: 34071582
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Computational investigation on
    Murugan NA; Pandian CJ; Jeyakanthan J
    J Biomol Struct Dyn; 2021 Aug; 39(12):4415-4426. PubMed ID: 32543978
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Multidimensional virtual screening approaches combined with drug repurposing to identify potential covalent inhibitors of SARS-CoV-2 3CL protease.
    Wang Y; Gao Q; Yao P; Yao Q; Zhang J
    J Biomol Struct Dyn; 2023; 41(24):15262-15285. PubMed ID: 36961210
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay.
    Narayanan A; Narwal M; Majowicz SA; Varricchio C; Toner SA; Ballatore C; Brancale A; Murakami KS; Jose J
    Commun Biol; 2022 Feb; 5(1):169. PubMed ID: 35217718
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development.
    Lv Z; Cano KE; Jia L; Drag M; Huang TT; Olsen SK
    Front Chem; 2021; 9():819165. PubMed ID: 35186898
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV.
    Lee H; Lei H; Santarsiero BD; Gatuz JL; Cao S; Rice AJ; Patel K; Szypulinski MZ; Ojeda I; Ghosh AK; Johnson ME
    ACS Chem Biol; 2015 Jun; 10(6):1456-65. PubMed ID: 25746232
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Structure-based virtual screening, molecular dynamics and binding affinity calculations of some potential phytocompounds against SARS-CoV-2.
    Naik SR; Bharadwaj P; Dingelstad N; Kalyaanamoorthy S; Mandal SC; Ganesan A; Chattopadhyay D; Palit P
    J Biomol Struct Dyn; 2022 Sep; 40(15):6921-6938. PubMed ID: 33682632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.